Amarin Corp. (AMRN)
1.82
-0.03 (1.62%)
Upcoming Events
Latest Headlines
Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: Zulueta Alfonso G
June 29, 2022 8:09 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: ENRIGHT ERIN S.
June 29, 2022 8:08 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: VAN HEEK G JAN
June 29, 2022 8:08 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: Peterson Kristine
June 29, 2022 8:07 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: O'Sullivan Patrick J
June 29, 2022 8:06 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: Ekman Lars
June 29, 2022 8:05 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jun 27 Filed by: WOLD OLSEN PER
June 29, 2022 8:04 PM - SEC Filing
Greater Competition Does Not Impact Investment Thesis - Cantor Fitzgerald Reiterates Amarin Corporation (AMRN)at Overweight
June 22, 2022 5:44 PM - StreetInsider
Form DEFA14A AMARIN CORP PLC\UK
June 17, 2022 4:52 PM - SEC Filing
Form SC 13D/A AMARIN CORP PLC\UK Filed by: Sarissa Capital Management LP
June 16, 2022 6:05 AM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jun 13 Filed by: WOLD OLSEN PER
June 15, 2022 8:02 PM - SEC Filing
Sarissa Capital Intends to Vote “Abstain” at the Amarin Annual Meeting
June 15, 2022 4:50 PM - BizWire
Amarin Corp. (AMRN) Announces Positive Recommendation from UK's NICE for Reimbursement of VAZKEPA
June 10, 2022 6:00 AM - StreetInsider
Amarin Receives Positive Recommendation from United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl)
June 10, 2022 6:00 AM - Globe NewsWire
Amarin Receives Positive Recommendation from United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl)
June 10, 2022 6:00 AM - StreetInsider
Form 8-K AMARIN CORP PLC\UK For: Jun 01
June 6, 2022 4:36 PM - SEC Filing
JPMorgan on Underweight-rated Amarin Corporation (AMRN), 'we see a difficult path ahead for the stock'
June 6, 2022 12:12 PM - StreetInsider
Amarin to slash jobs as generic rivals dull U.S. prospects of heart drug
June 6, 2022 9:34 AM - StreetInsider
Amarin Corp. (AMRN) Announces Comprehensive Cost Reduction Plan
June 6, 2022 8:33 AM - StreetInsider
Amarin Announces Comprehensive Cost Reduction Plan to Address Market Dynamics in U.S. Business
June 6, 2022 8:30 AM - Globe NewsWire
Amarin Announces Comprehensive Cost Reduction Plan to Address Market Dynamics in U.S. Business
June 6, 2022 8:30 AM - StreetInsider
Amarin Corp. (AMRN) Appoints Tom Reilly as New Chief Financial Officer
June 6, 2022 8:16 AM - StreetInsider
Amarin Appoints Tom Reilly as New Chief Financial Officer
June 6, 2022 8:15 AM - Globe NewsWire
Amarin Appoints Tom Reilly as New Chief Financial Officer
June 6, 2022 8:15 AM - StreetInsider
Sarissa Capital held talks with Amarin Corp. (AMRN) on ways to maximize value
June 3, 2022 9:29 AM - StreetInsider
Form SC 13D/A AMARIN CORP PLC\UK Filed by: Sarissa Capital Management LP
June 3, 2022 9:18 AM - SEC Filing
Form DEF 14A AMARIN CORP PLC\UK For: Jun 27
May 24, 2022 5:17 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: May 16 Filed by: Zulueta Alfonso G
May 20, 2022 8:25 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: May 16 Filed by: ENRIGHT ERIN S.
May 20, 2022 8:25 PM - SEC Filing
Form 3 AMARIN CORP PLC\UK For: May 16 Filed by: Zulueta Alfonso G
May 20, 2022 8:23 PM - SEC Filing
Form 3 AMARIN CORP PLC\UK For: May 16 Filed by: ENRIGHT ERIN S.
May 20, 2022 8:23 PM - SEC Filing
Form 8-K AMARIN CORP PLC\UK For: May 16
May 20, 2022 7:48 AM - SEC Filing
Amarin Corp. (AMRN) Appoints Erin Enright and Alfonso Zulueta to its Board, Announces Leadership Changes
May 19, 2022 8:24 AM - StreetInsider
Amarin Corp. (AMRN) Appoints Erin Enright and Alfonso Zulueta to its Board, Announces Leadership Changes
May 19, 2022 8:24 AM - StreetInsider
Amarin Corp. (AMRN) Appoints Erin Enright and Alfonso Zulueta to its Board, Announces Leadership Changes
May 19, 2022 8:24 AM - StreetInsider
Amarin Corp. (AMRN) Appoints Erin Enright and Alfonso Zulueta to its Board, Announces Leadership Changes
May 19, 2022 8:24 AM - StreetInsider
Amarin Corp. (AMRN) Appoints Erin Enright and Alfonso Zulueta to its Board, Announces Leadership Changes
May 19, 2022 8:24 AM - StreetInsider
Amarin Announces Appointment of New Directors and Board Leadership Changes
May 19, 2022 8:24 AM - StreetInsider
Amarin Announces Appointment of New Directors and Board Leadership Changes
May 19, 2022 8:23 AM - Globe NewsWire
Amarin Corp. (AMRN) Reports Research Supporting Potential for VASCEPA to Reduce Major Adverse Cardiovascular (CV) Events and Associated Costs
May 16, 2022 8:04 AM - StreetInsider
Research Presented at the American Heart Association’s Quality of Care and Outcomes Research (QCOR) Scientific Sessions Indicate Potential for VASCEPA® (icosapent ethyl) to Reduce Major Adverse Car
May 16, 2022 8:00 AM - Globe NewsWire
Research Presented at the American Heart Association’s Quality of Care and Outcomes Research (QCOR) Scientific Sessions Indicate Potential for VASCEPA® (icosapent ethyl) to Reduce Major Adverse Car
May 16, 2022 8:00 AM - StreetInsider
Amarin to Present at Two Upcoming Investor Conferences
May 12, 2022 8:01 AM - StreetInsider
Amarin to Present at Two Upcoming Investor Conferences
May 12, 2022 8:00 AM - Globe NewsWire
UPDATE: JPMorgan Downgrades Amarin Corporation (AMRN) to Underweight
May 6, 2022 3:34 AM - StreetInsider
H.C. Wainwright Downgrades Amarin Corporation (AMRN) to Neutral
May 5, 2022 6:14 AM - StreetInsider
SVB Leerink Downgrades Amarin Corporation (AMRN) to Market Perform
May 5, 2022 6:09 AM - StreetInsider
Northland Capital Markets Downgrades Amarin Corporation (AMRN) to Market Perform
May 4, 2022 3:27 PM - StreetInsider
Amarin Corporation (AMRN) PT Lowered to $9 at Cowen
May 4, 2022 12:55 PM - StreetInsider
Form 8-K AMARIN CORP PLC\UK For: May 04
May 4, 2022 7:10 AM - SEC Filing
Form 10-Q AMARIN CORP PLC\UK For: Mar 31
May 4, 2022 7:06 AM - SEC Filing
Amarin Corp. (AMRN) Misses Q1 EPS by 6c
May 4, 2022 7:04 AM - StreetInsider
Amarin Reports First Quarter 2022 Financial Results and Provides Business Update
May 4, 2022 7:00 AM - Globe NewsWire
Form 4 AMARIN CORP PLC\UK For: May 02 Filed by: Marks Jason M.
May 3, 2022 8:04 PM - SEC Filing
Amarin Corp. (AMRN) Reports New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction
May 3, 2022 8:12 AM - StreetInsider
New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction (Heart Attack)
May 3, 2022 8:00 AM - Globe NewsWire
New Analysis Reveals Icosapent Ethyl Significantly Reduces Risk of Major Cardiovascular Events in Patients with Prior Myocardial Infarction (Heart Attack)
May 3, 2022 8:00 AM - StreetInsider
Form 10-K/A AMARIN CORP PLC\UK For: Dec 31
May 2, 2022 4:03 PM - SEC Filing
Amarin Corp. (AMRN) Partner HLS Therapeutics Completes Reimbursement Negotiations with Pan-Canadian Pharmaceutical Alliance for VASCEPA
April 26, 2022 8:50 AM - StreetInsider
Amarin Partner HLS Therapeutics Completes Reimbursement Negotiations with Pan-Canadian Pharmaceutical Alliance (pCPA) for VASCEPA® (icosapent ethyl)
April 26, 2022 8:50 AM - StreetInsider
Amarin Partner HLS Therapeutics Completes Reimbursement Negotiations with Pan-Canadian Pharmaceutical Alliance (pCPA) for VASCEPA® (icosapent ethyl)
April 26, 2022 8:49 AM - Globe NewsWire
Amarin to Report First Quarter 2022 Financial Results and Host Conference Call On May 4, 2022
April 19, 2022 7:30 AM - Globe NewsWire
Amarin to Report First Quarter 2022 Financial Results and Host Conference Call On May 4, 2022
April 19, 2022 7:30 AM - StreetInsider
Form 4 AMARIN CORP PLC\UK For: Apr 12 Filed by: Mikhail Karim
April 14, 2022 8:03 PM - SEC Filing
Amarin Corp. (AMRN) Announces Eicosapentaenoic Acid Combined with Widely Used Statins Significantly Reduced Lipid Oxidation in Model Membranes
April 1, 2022 7:03 AM - StreetInsider
Eicosapentaenoic Acid (EPA) Combined with Widely Used Statins Significantly Reduced Lipid Oxidation in Model Membranes
April 1, 2022 7:00 AM - Globe NewsWire
Eicosapentaenoic Acid (EPA) Combined with Widely Used Statins Significantly Reduced Lipid Oxidation in Model Membranes
April 1, 2022 7:00 AM - StreetInsider
Full Article List
